Thromboembolic disease, also known as venous thromboembolism (VTE), affects approximately 15%
Of all cancer patients and represents the second leading cause of death in cancer patients.
Thromboembolic means blood clot formed due to blood due to cancer.
Various factors are associated with an increased risk of thromboembolic disease like disseminated
Cancer, Cytotoxic agents, thalidomide, hormonal therapy (tamoxifen and medroxyprogesterone),
Venous stasis (extrinsic compression), restricted mobility, hospitalization, Vessel trauma, surgery etc.
Prophylactic use of anti-coagulant therapy like Low-dose warfarin and heparin can be helpful in
Patients with advanced cancer.
It is the most fatal event in thrombo-embolic episodes which could lead to sudden death.
The diagnosis can be made by a positive chest computed tomography (CT) or pulmonary angiogram.